Tranexamic acid therapy for heavy menstrual bleeding

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 13, 2011, Pages 2089-2095

  Lumsden, Mary Ann ^a   Wedisinghe, Lilantha ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

Author keywords

antifibrinolytic; heavy menstrual bleeding; menorrhagia; tranexamic acid

Indexed keywords

CYKLO F; DESMOPRESSIN; DICLOFENAC; ETAMSYLATE; FLURBIPROFEN; GESTAGEN; GONADORELIN DERIVATIVE; LEVONORGESTREL; LYSTEDA; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PLACEBO; PLASMA PROTEIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ACNE; AMENORRHEA; ASTHMA; BLOATING; BONE DENSITY; BREAST TENDERNESS; CLINICAL TRIAL (TOPIC); COLOR VISION DEFECT; CONVULSION; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DEPRESSION; DIARRHEA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; DYSPEPSIA; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; FLUID RETENTION; GOVERNMENT REGULATION; HEART INFARCTION; HOT FLUSH; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INDIGESTION; LOW DRUG DOSE; MENORRHAGIA; MENSTRUAL IRREGULARITY; MENTAL INSTABILITY; MYOMECTOMY; NAUSEA; OSTEOPOROSIS; PATIENT CARE; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PERITONITIS; PLASMA PROTEIN BINDING; PREGNANCY; PREMENSTRUAL LIKE SYNDROME; PREMENSTRUAL SYNDROME; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; SKIN ALLERGY; STROKE; SWEATING; THROMBOEMBOLISM; UTERINE ARTERY EMBOLIZATION; VAGINAL DRYNESS; VENOUS THROMBOEMBOLISM; VISUAL DISORDER; VOMITING; WEIGHT GAIN;

ANTIFIBRINOLYTIC AGENTS; FEMALE; HUMANS; MENORRHAGIA; MENSTRUATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANEXAMIC ACID;

EID: 80051501954     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2011.598857     Document Type: Review

References (37)

1. National Collaborating Centre for Women's and Children's Health. Heavy Menstrual Bleeding. London: RCOG Press; 2007. Available from: Http://guidance.nice.org.uk/CG44
2. Smith SK, Smith SK. Hysterectomy-why and when? In: Smith SK. editor. Dysfunctional uterine bleeding. Royal Society of Medicine Press; London: 1994. p. 107
3. Oehler MK, Rees MC. Menorrhagia: An update. Acta Obstet Gynecol Scand 2003;82:405-22 (Pubitemid 36629848)
4. Shankar M, Lee CA, Sabin CA, et al. von Willebrand disease in women with menorrhagia: A systematic review. BJOG 2004;111(7):734-40 (Pubitemid 38869763)
5. Wedisinghe L, Lumsden MA. Heavy Menstrual Bleeding. In: Mahmood T, Templeton A, Dhillon C. editors. Models of Care in Women's Health. RCOG Press; London: 2009. p. 67-80
6. British National Formulary. (Volume 61). BMJ Publishing Group Ltd and RPS Publishing, London; 2011
7. Coulter A, Kelland J, Peto V, Rees MC. Menorrhagia in primary care: An overview of drug trials and a survey of prescribing practice. Int J Technol Assess Health Care 1995;11(3):456-71
8. Wellington K, Wagstaff AJ. Tranexamic acid: A review of its use in the management of menorrhagia. Drugs 2003;63(13):1417-33 (Pubitemid 36776096)
9. Thorsen S. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degredation: Influence of omega-aminocarboxylic acids. Biochim Biophys Acta 1975;393:55-65
10. Gleeson NC, Buggy F, Sheppard BL, et al. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstet Gynecol Scand 1994;73:274-7 (Pubitemid 24074449)
11. Dockeray CJ, Sheppard BL, Daily L, Bonnar J. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. Eur J Obstet Gynecol Reprod Biol 1987;24(4):309-18 (Pubitemid 17065272)
12. Moodley J, Cohen M, Devraj K, Dutton M. Vaginal absorption of low-dose tranexamic acid from impregnated tampons. S Afr Med J 1992;81(3):150-2
13. Eriksson O, Kjellman H, Schannong M. The biological availability of Cyklokapron solution administered orally. Data on file, Kabi AB; Stockholm: 1971
14. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985;29(3):236-61 (Pubitemid 15144749)
15. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: Randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996;313:579-82 (Pubitemid 26293640)
16. Preston JT, Cameron IT, Adams EJ, et al. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol 1995;102(5):401-6
17. Milsom I, Andersson K, Andersch B, et al. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991;164(3):879-83
18. Callender ST, Warner GT, Cope E. Treatment of menorrhagia with tranexamic acid: A double-blind trial. BMJ 1970;4(729):214-16
19. Ylikorkala O, Viinikka L. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. Br J Obstet Gynaecol 1983;90(1):78-83 (Pubitemid 13224187)
20. Srinil S, Jaisamrarn U. Treatment of idiopathic menorrhagia with tranexamic acid. J Med Assoc Thai 2005;88(2):S1-6
21. Kouides PA, Byams VR, Philipp CS, et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: A prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol 2009;145(2):212-20
22. Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: A randomized controlled trial. Obstet Gynecol 2010;116(4):865-75
23. Winkler UH. The effect of tranexamic acid on the quality of life of women with heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol 2001;99(2):238-43 (Pubitemid 34098754)
24. Lethaby A, Farquar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000(4):CD000249
25. Demers C, Derzko C, Douglas J. Ggynecological and obstetric management of women with inherited bleeding disorders. Int J Gynecol Obstet 2006;95(1):75-87
26. Kadir RA, Lukes AS, Kouides PA, et al. Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril 2005;84:1352-9 (Pubitemid 41571881)
27. Kullander S, Nilsson IM. Human placental transfer Aof an antifibrinolytic agent (AMCA). Acta Obstet Gynecol Scand 1970;49(3):241-2
28. Nilsson IM. Haemorrhage and Thrombotic Diseases. John Wiley & Sins, Ltd; London: 1974
29. Taparia M, Cordingley FT, Leahy MF. Pulmonary embolism associated with tranexamic acid in severe acqired haemophelia. Eur J Hematol 2002;68:307-9
30. Woo KS, Tse LK, Woo JL, Vallance-Owen J. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy. Br J Clin Pract 1989;43:465-6 (Pubitemid 20017351)
31. Dunn CJ, Goa KL. TA: A review of its use in surgery and other indications. Drugs 1999;57(6):1005-32 (Pubitemid 29313210)
32. Hippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997;84:839-44 (Pubitemid 27147712)
33. Zhang B, Wieslander JB. Influence of early fibrinolysis inhibition on thrombus formation following microvascular trauma. Microsurgery 1996;17:278-85 (Pubitemid 27284254)
34. Lindoff C, Rybo G, Astedt B. Treatment with tranexamic acid during pregnancy, and risk of thrombo-embolic complications. Thromb Haemost 1993;70:238-40 (Pubitemid 23222474)
35. Sundstrom A, Seaman H, Kieler H, Alfredsson L. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: A case-control study using the General Practice Research Database. Br J Obstet Gynaecol 2009;116:91-7
36. Rybo G. Tranexamic acid therapy: Effective treatment in heavy menstrual bleeding: Clinical update on safety. Ther Adv 1991;4:1-8
37. Winkler UH. The effect of tranexamic acid on the quality of life of women with heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol 2001;99(2):238-43 (Pubitemid 34098754)